R&D
Taiho and Cullinan’s Lung Cancer Drug Aces a Phase 3 Trial, Heating Up a Crowded Race
Zipalertinib plus chemo so clearly slowed a hard-to-treat form of lung cancer that the trial was stopped early — setting up a fight with drugs from J&J and AstraZeneca.